Targeting molecular and genetic pathways driving tumorigenesis for precision therapy in colorectal cancer
Allison S Doermann, Adi Caspi, Andrew E Evans, Andrea Feci, Ariana A Entezari, Adam E Snook, Scott A Waldman · 2026
Read Targeting molecular and genetic pathways driving tumorigenesis for precision therapy in colorectal cancer by Allison S Doermann, Adi Caspi, Andrew E Evans, Andrea Feci, Ariana A Entezari, Adam E Snook, Scott A Waldman (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13418715.txt.
Description
Allison S Doermann and colleagues review molecular pathways driving colorectal cancer and the precision treatments aimed at them, in a 2026 article. Bowel cancer is a leading cause of cancer death, and cases under age 50 are rising. Tumours grow by corrupting networks that control cell growth, survival, differentiation, and immune interaction.
Six major pathways receive detailed treatment, from the Wnt growth circuit to the p53 guardian and TGF beta signalling. Genetic and epigenetic hallmarks are layered over that map. Conventional therapy and new mutation targeted strategies are then judged against the pathway picture, aiming for treatments matched to each tumour's wiring.
Catalog record
| CREATOR | Allison S Doermann, Adi Caspi, Andrew E Evans, Andrea Feci, Ariana A Entezari, Adam E Snook, Scott A Waldman |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 67 KB |
| LICENSE | https://creativecommons.org/licenses/by/4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |